Hidden lung threat in cystic fibrosis: nationwide hunt for silent bacteria
NCT ID NCT03312075
Summary
This study aimed to understand how common and serious infections from non-tuberculous mycobacteria (NTM) are in people with cystic fibrosis in France. Researchers observed 848 patients to measure how many had these bacteria in their lungs and tested a new blood test to detect past exposure. The goal was to gather better information to help doctors diagnose and manage these complex infections in the future.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AP-HP Hôpital Cochin
Paris, 75679, France
-
AP-HP Hôpital Foch
Suresnes, 92151, France
-
CHIC Créteil
Créteil, 94000, France
-
CHR Sud Réunion
Saint-Pierre, 97410, France
-
CHRU Brest
Brest, 29200, France
-
CHU Amiens
Amiens, Amiens, 80054, France
-
CHU Bordeaux
Pessac, 33604, France
-
CHU Côte de Nacre
Caen, 14033, France
-
CHU Grenoble
Grenoble, 38043, France
-
CHU Lille
Lille, 59037, France
-
CHU Rouen
Rouen, 76031, France
-
CHU Toulouse
Toulouse, 31059, France
-
CHU Tours
Tours, 37044, France
-
Centre de Perharidy
Roscoff, 29684, France
Conditions
Explore the condition pages connected to this study.